You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 6, June 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Genetic Counseling/ Testing/ Therapy
 •Genetic Disorders
 •Neurogenetics
 •Movement Disorders
 •Parkinson Disease/ Parkinsonian Disorders
 •Alert me on articles by topic

An Apparently Sporadic Case With Parkin Gene Mutation in a Korean Woman

Beom S. Jeon, MD, PhD; Jong-Min Kim, MD; Dong-Soo Lee, MD, PhD; Nobutaka Hattori, MD, PhD; Yoshikuni Mizuno, MD, PhD

Arch Neurol. 2001;58:988-989.

Objective  To report the clinical features and results of iodine I 123-2ß-carbomethoxy-3ß-(4-iodophenyl)-tropane (CIT) single photon emission computed tomography and molecular genetic analysis in a Korean woman with juvenile Parkinson disease with deletion in exon 4 of the parkin gene.

Design  Case report with molecular genetic analysis.

Patient and Results  The patient had bradykinesia, postural imbalance, and postural tremor since the age of 12 years. She developed wearing off early in the disease course. The [123I]-2ß-carbomethoxy-3ß-(4-iodophenyl)-tropane single photon emission computed tomography showed severe reduction of specific striatal CIT binding, comparable to that of Parkinson disease. The polymerase chain reaction products from the parkin gene showed homozygous exon 4 deletion.

Conclusion  In this sporadic juvenile Parkinson disease case, severe nigrostriatal dopaminergic damage and homozygous exon 4 deletion in the parkin gene were demonstrated.


From the Departments of Neurology (Drs Jeon and Kim) and Nuclear Medicine (Dr Lee), Seoul National University College of Medicine, and the National University Hospital, Clinical Research Institute (Drs Jeon, Kim, and Lee), Seoul, South Korea and the Department of Neurology, Juntendo University College of Medicine, Tokyo, Japan (Drs Hattori and Mizuno).

Corresponding author and reprints: Beom S. Jeon, MD, PhD, Department of Neurology, Movement Disorder Division, Seoul National University Hospital, Chongno-Ku Yunkeun-Dong 28, Seoul 110-744, South Korea (e-mail: jeonmd{at}snu.ac.kr).


RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(6):1028-1029.
FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.